High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer
Author:
Funder
Foundation for the National Institutes of Health
U.S. Department of Defense
Roswell Park Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06552-0.pdf
Reference76 articles.
1. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366–374. https://doi.org/10.1038/35077232
2. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182. https://doi.org/10.1016/s0092-8674(02)00615-3
3. Teraoka S, Muguruma M, Takano N, Miyahara K, Kawate T, Kaise H, Yamada K, Miyazawa K, Ishikawa T (2020) Association of BRCA Mutations and BRCAness status with anticancer drug sensitivities in triple-negative breast cancer cell lines. J Surg Res 250:200–208. https://doi.org/10.1016/j.jss.2019.12.040
4. Teraoka S, Sato E, Narui K, Yamada A, Fujita T, Yamada K, Oba M, Ishikawa T (2020) Neoadjuvant chemotherapy with anthracycline-based regimen for BRCAness tumors in triple-negative breast cancer. J Surg Res 250:143–147. https://doi.org/10.1016/j.jss.2019.12.047
5. Turner N, Tutt A, Ashworth A (2004) Hallmarks of “BRCAness” in sporadic cancers. Nat Rev Cancer 4:814–819. https://doi.org/10.1038/nrc1457
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RAD51 High-Expressed Hepatocellular Carcinomas are Associated With High Cell Proliferation;Journal of Surgical Research;2024-10
2. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer;Breast Cancer Research and Treatment;2024-07-17
3. Targeting DNA Damage Response Deficiency in Thoracic Cancers;Drugs;2024-07-13
4. Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression;Breast Cancer Research and Treatment;2024-07-07
5. Integrative Pan-Cancer Analysis Reveals the Oncogenic Role of MND1 and Validation of MND1’s Role in Breast Cancer;Journal of Inflammation Research;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3